Responses to 177Lu-DOTATATE differ according to primary and metastatic sites, researchers reported in a retrospective study.

Researchers assessed the impact of pretreatment counseling on patient-reported outcomes in patients with hepatocellular carcinoma on immunotherapy.

Liver transplantation is linked to durable survival for patients with neuroendocrine liver metastases, but careful patient ...

Zocilurtatug pelitecan has shown clinically meaningful responses and manageable safety in heavily pretreated patients with ...

First-line treatment duration may be a clinically useful predictor for 177Lu-DOTATATE retreatment patient selection, ...

NETest2.0 accurately identified active NET disease and provided clinically meaningful longitudinal surveillance information.

Researchers evaluated venetoclax plus pediatric-inspired chemotherapy for Philadelphia chromosome-negative ALL.

According to data from the SwissNET registry of patients with GI-NETS, response to [177Lu]Lu-edotreotide is not influenced by ...

Nearly 20% of patients with M0 pancreatic neuroendocrine tumors (pNETS) go on to develop metastases within 4 years after ...

Patients with NETS who have lower physical activity levels have greater fatigue and worse quality of life than those who are more physically active.

Cabozantinib improves PFS over placebo in patients with functional or nonfunctional extrapancreatic or pancreatic ...

Odds of radiotherapy nonadherence and three-year recurrence risk both lower, while disease-free survival improved ...